Pneumocystis Pneumonia

Pneumocystis pneumonia (PcP) in humans is caused by Pneumocystis jirovecii, which has recently been reclassified as a fungus because its cell wall composition and nucleotide sequences are more similar to those of fungi. PcP occurs only in immunocompromised individuals such as those with AIDS. Despit...

Full description

Bibliographic Details
Main Authors: Jang-Jih Lu, Chao-Hung Lee
Format: Article
Language:English
Published: Elsevier 2008-11-01
Series:Journal of the Formosan Medical Association
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664608601990
_version_ 1818153762573778944
author Jang-Jih Lu
Chao-Hung Lee
author_facet Jang-Jih Lu
Chao-Hung Lee
author_sort Jang-Jih Lu
collection DOAJ
description Pneumocystis pneumonia (PcP) in humans is caused by Pneumocystis jirovecii, which has recently been reclassified as a fungus because its cell wall composition and nucleotide sequences are more similar to those of fungi. PcP occurs only in immunocompromised individuals such as those with AIDS. Despite the use of highly active antiretroviral therapy, PcP remains the leading opportunistic infection in AIDS patients. Based on nucleotide sequence variations in the internal transcribed spacer region of rRNA genes, more than 60 different types of P. jirovecii have been identified. Although type differences do not appear to correlate with the clinical characteristics of PcP, nucleotide sequence variations of the organism have been useful in epidemiologic studies. As a result, some recurrent infections are found to be due to re-infection with new types, and outbreaks due to the same types of P. jirovecii have been identified. Initial diagnosis of PcP is usually based on symptoms and chest radiography. A characteristic histopathologic feature is the presence of acellular eosinophilic exudates and organisms in the alveoli. Ultimate diagnosis of PcP is achieved by demonstration of the organism in induced sputum or bronchoalveolar lavage fluid by tinctorial staining or polymerase chain reaction (PCR). Among the many different PCR methods, the nested PCR that targets the large subunit mitochondrial rRNA gene is the most sensitive and specific. Combination of trimethoprim and sulfamethoxazole is the first choice of drugs for both treatment and prophylaxis of PcP. Other drugs that can be used include a combination of primaquine and clindamycin, pentamidine, atovaquone, and a combination of dapsone and trimethoprim. Pneumocystis organisms have the ability to inactivate the phagocytic activity of alveolar macrophages and to induce them to undergo apoptosis. This apoptosis is due to activation of caspase 9 by polyamines that are present in high levels in the lung and alveolar macrophages during PcP.
first_indexed 2024-12-11T14:15:46Z
format Article
id doaj.art-62edabb1fc9a4ef083b014592e50ac53
institution Directory Open Access Journal
issn 0929-6646
language English
last_indexed 2024-12-11T14:15:46Z
publishDate 2008-11-01
publisher Elsevier
record_format Article
series Journal of the Formosan Medical Association
spelling doaj.art-62edabb1fc9a4ef083b014592e50ac532022-12-22T01:03:10ZengElsevierJournal of the Formosan Medical Association0929-66462008-11-011071183084210.1016/S0929-6646(08)60199-0Pneumocystis PneumoniaJang-Jih Lu0Chao-Hung Lee1Department of Laboratory Medicine, China Medical University Hospital, Taichung, Taipei, TaiwanDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USAPneumocystis pneumonia (PcP) in humans is caused by Pneumocystis jirovecii, which has recently been reclassified as a fungus because its cell wall composition and nucleotide sequences are more similar to those of fungi. PcP occurs only in immunocompromised individuals such as those with AIDS. Despite the use of highly active antiretroviral therapy, PcP remains the leading opportunistic infection in AIDS patients. Based on nucleotide sequence variations in the internal transcribed spacer region of rRNA genes, more than 60 different types of P. jirovecii have been identified. Although type differences do not appear to correlate with the clinical characteristics of PcP, nucleotide sequence variations of the organism have been useful in epidemiologic studies. As a result, some recurrent infections are found to be due to re-infection with new types, and outbreaks due to the same types of P. jirovecii have been identified. Initial diagnosis of PcP is usually based on symptoms and chest radiography. A characteristic histopathologic feature is the presence of acellular eosinophilic exudates and organisms in the alveoli. Ultimate diagnosis of PcP is achieved by demonstration of the organism in induced sputum or bronchoalveolar lavage fluid by tinctorial staining or polymerase chain reaction (PCR). Among the many different PCR methods, the nested PCR that targets the large subunit mitochondrial rRNA gene is the most sensitive and specific. Combination of trimethoprim and sulfamethoxazole is the first choice of drugs for both treatment and prophylaxis of PcP. Other drugs that can be used include a combination of primaquine and clindamycin, pentamidine, atovaquone, and a combination of dapsone and trimethoprim. Pneumocystis organisms have the ability to inactivate the phagocytic activity of alveolar macrophages and to induce them to undergo apoptosis. This apoptosis is due to activation of caspase 9 by polyamines that are present in high levels in the lung and alveolar macrophages during PcP.http://www.sciencedirect.com/science/article/pii/S0929664608601990CD4-positive T-lymphocytesgenotypeHIV infectionsPneumocystis pneumoniatrimethoprim-sulfamethoxazole
spellingShingle Jang-Jih Lu
Chao-Hung Lee
Pneumocystis Pneumonia
Journal of the Formosan Medical Association
CD4-positive T-lymphocytes
genotype
HIV infections
Pneumocystis pneumonia
trimethoprim-sulfamethoxazole
title Pneumocystis Pneumonia
title_full Pneumocystis Pneumonia
title_fullStr Pneumocystis Pneumonia
title_full_unstemmed Pneumocystis Pneumonia
title_short Pneumocystis Pneumonia
title_sort pneumocystis pneumonia
topic CD4-positive T-lymphocytes
genotype
HIV infections
Pneumocystis pneumonia
trimethoprim-sulfamethoxazole
url http://www.sciencedirect.com/science/article/pii/S0929664608601990
work_keys_str_mv AT jangjihlu pneumocystispneumonia
AT chaohunglee pneumocystispneumonia